: Patterns of receptors for chemotactic factors regulate the homing of leukocytes to tissues. Here we report that the CCRL2/chemerin/CMKLR1 axis represents a selective pathway for the homing of natural killer (NK) cells to the lung. C-C motif chemokine receptor-like 2 (CCRL2) is a nonsignaling seven-transmembrane domain receptor able to control lung tumor growth. CCRL2 constitutive or conditional endothelial cell targeted ablation, or deletion of its ligand chemerin, were found to promote tumor progression in a Kras/p53Flox lung cancer cell model. This phenotype was dependent on the reduced recruitment of CD27- CD11b+ mature NK cells. Other chemotactic receptors identified in lung-infiltrating NK cells by single-cell RNA sequencing (scRNA-seq), such as Cxcr3, Cx3cr1, and S1pr5, were found to be dispensable in the regulation of NK-cell infiltration of the lung and lung tumor growth. scRNA-seq identified CCRL2 as the hallmark of general alveolar lung capillary endothelial cells. CCRL2 expression was epigenetically regulated in lung endothelium and it was upregulated by the demethylating agent 5-aza-2'-deoxycytidine (5-Aza). In vivo administration of low doses of 5-Aza induced CCRL2 upregulation, increased recruitment of NK cells, and reduced lung tumor growth. These results identify CCRL2 as an NK-cell lung homing molecule that has the potential to be exploited to promote NK cell-mediated lung immune surveillance.

CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer / Sozio, Francesca; Schioppa, Tiziana; Laffranchi, Mattia; Salvi, Valentina; Tamassia, Nicola; Bianchetto-Aguilera, Francisco M; Tiberio, Laura; Bonecchi, Raffaella; Bosisio, Daniela; Parmentier, Marc; Bottazzi, Barbara; Leone, Roberto; Russo, Eleonora; Bernardini, Giovanni; Garofalo, Stefano; Limatola, Cristina; Gismondi, Angela; Sciume, Giuseppe; Mantovani, Alberto; Del Prete, Annalisa; Sozzani, Silvano. - In: CANCER IMMUNOLOGY RESEARCH. - ISSN 2326-6066. - 11:9(2023), pp. 1280-1295. [10.1158/2326-6066.CIR-22-0951]

CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer

Sozio, Francesca;Schioppa, Tiziana;Laffranchi, Mattia;Bonecchi, Raffaella;Russo, Eleonora;Bernardini, Giovanni;Garofalo, Stefano;Limatola, Cristina;Gismondi, Angela;Sciume, Giuseppe;Del Prete, Annalisa;Sozzani, Silvano
2023

Abstract

: Patterns of receptors for chemotactic factors regulate the homing of leukocytes to tissues. Here we report that the CCRL2/chemerin/CMKLR1 axis represents a selective pathway for the homing of natural killer (NK) cells to the lung. C-C motif chemokine receptor-like 2 (CCRL2) is a nonsignaling seven-transmembrane domain receptor able to control lung tumor growth. CCRL2 constitutive or conditional endothelial cell targeted ablation, or deletion of its ligand chemerin, were found to promote tumor progression in a Kras/p53Flox lung cancer cell model. This phenotype was dependent on the reduced recruitment of CD27- CD11b+ mature NK cells. Other chemotactic receptors identified in lung-infiltrating NK cells by single-cell RNA sequencing (scRNA-seq), such as Cxcr3, Cx3cr1, and S1pr5, were found to be dispensable in the regulation of NK-cell infiltration of the lung and lung tumor growth. scRNA-seq identified CCRL2 as the hallmark of general alveolar lung capillary endothelial cells. CCRL2 expression was epigenetically regulated in lung endothelium and it was upregulated by the demethylating agent 5-aza-2'-deoxycytidine (5-Aza). In vivo administration of low doses of 5-Aza induced CCRL2 upregulation, increased recruitment of NK cells, and reduced lung tumor growth. These results identify CCRL2 as an NK-cell lung homing molecule that has the potential to be exploited to promote NK cell-mediated lung immune surveillance.
2023
lung cancer; chemokines; NK cells; endothelial cells
01 Pubblicazione su rivista::01a Articolo in rivista
CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer / Sozio, Francesca; Schioppa, Tiziana; Laffranchi, Mattia; Salvi, Valentina; Tamassia, Nicola; Bianchetto-Aguilera, Francisco M; Tiberio, Laura; Bonecchi, Raffaella; Bosisio, Daniela; Parmentier, Marc; Bottazzi, Barbara; Leone, Roberto; Russo, Eleonora; Bernardini, Giovanni; Garofalo, Stefano; Limatola, Cristina; Gismondi, Angela; Sciume, Giuseppe; Mantovani, Alberto; Del Prete, Annalisa; Sozzani, Silvano. - In: CANCER IMMUNOLOGY RESEARCH. - ISSN 2326-6066. - 11:9(2023), pp. 1280-1295. [10.1158/2326-6066.CIR-22-0951]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1692993
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact